Brief: United States Patent And Trademark Office (USPTO) Grants Evoke Pharma A Formulation Patent Covering Gimoti
April 20 (Reuters) - Evoke Pharma Inc EVOK.O :
* UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) GRANTS
EVOKE
PHARMA A FORMULATION PATENT COVERING GIMOTI
* EVOKE PHARMA INC - PATENT COVERING GIMOTI EXPIRES IN 2029
AND
COVERS NASAL SOLUTION OF METOCLOPRAMIDE AND ITS CHARACTERISTICS
WHEN FORMULATED
* EVOKE PHARMA INC - COMPANY WILL SEEK TO LIST THIS PATENT
IN FDA
ORANGE-BOOK IN NEAR TERM
Source text for Eikon: ID:nGNX6yz1pF
Further company coverage: EVOK.O
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary